These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35065173)

  • 1. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province.
    Decker KM; Feely A; Bucher O; Singh H; Turner D; Lambert P
    Prev Med; 2022 Feb; 155():106961. PubMed ID: 35065173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P
    Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.
    Joung RH; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Bilimoria KY; Cance WG; Nelson H;
    JAMA Netw Open; 2022 Nov; 5(11):e2242354. PubMed ID: 36383381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba.
    Decker KM; Lambert P; Feely A; Bucher O; Kim JO; Hebbard P; Thiessen M; Fatoye T; Pitz M; Koul R; Czaykowski P
    Curr Oncol; 2021 Aug; 28(4):3081-3090. PubMed ID: 34436035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
    Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
    Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
    Duarte MBO; Argenton JLP; Carvalheira JBC
    JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region.
    Chiu HM; Su CW; Hsu WF; Jen GH; Hsu CY; Chen SL; Chen HH
    Prev Med; 2021 Oct; 151():106622. PubMed ID: 34044024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruptions in preventive care: Mammograms during the COVID-19 pandemic.
    Song H; Bergman A; Chen AT; Ellis D; David G; Friedman AB; Bond AM; Bailey JM; Brooks R; Smith-McLallen A
    Health Serv Res; 2021 Feb; 56(1):95-101. PubMed ID: 33146429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Association Between Sociodemographic Status and Breast Screening Volumes During the COVID-19 Pandemic in a Provincial, Population-Based Organized Breast Screening Program.
    Bentley H; Raveinthiranathan N; Mar C; Tang T; Regier DA; Chi K; Simkin J; Kellow Z; Yong-Hing CJ; Woods RR
    Can Assoc Radiol J; 2024 May; 75(2):253-260. PubMed ID: 37619596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysis.
    Lambert P; Galloway K; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Decker KM
    JNCI Cancer Spectr; 2024 Jan; 8(1):. PubMed ID: 38177077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 18. Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators.
    Jidkova S; Hoeck S; Kellen E; le Cessie S; Goossens MC
    BMC Cancer; 2022 Feb; 22(1):183. PubMed ID: 35177021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.
    Labaki C; Bakouny Z; Schmidt A; Lipsitz SR; Rebbeck TR; Trinh QD; Choueiri TK
    Cancer Cell; 2021 Aug; 39(8):1042-1044. PubMed ID: 34265251
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.